Determinants and prognostic importance of cardiomegaly among new ESRD patients in the United States

Annals of Epidemiology

Volumn 14, Issue 9, 2004, Pages 676-685

  Stack, Austin G ^a,b   Serna, Humberto ^a   Ramsanahie, Anthony ^a   Henry, Charles ^a  

^a Univ Texas Med Sch Houston H   (United Kingdom)

^b UNIVERSITY OF TEXAS   (United States)

Author keywords

adjusted odds ratio; Cardiomegaly; cardiovascular; CHF; Clinical Correlates; congestive heart failure; CVD; DMMS; end stage renal disease; ESRD; left ventricular hypertrophy; LVH; OR; Pre End stage Renal Disease Care; Survival

Indexed keywords

ERYTHROPOIETIN; SERUM ALBUMIN;

ADULT; AGED; ARTICLE; BODY MASS; CARDIOMEGALY; CARDIOVASCULAR RISK; COHORT ANALYSIS; CONTROLLED STUDY; CORRELATION ANALYSIS; DIABETES MELLITUS; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; DISEASE COURSE; ETHNOLOGY; FEMALE; HUMAN; HYPERTENSION; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PATIENT CARE; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; RADIOGRAPHY; RISK ASSESSMENT; RISK FACTOR; SMOKING; STATISTICAL SIGNIFICANCE; TOBACCO; UNITED STATES;

ADULT; AGED; CARDIOMEGALY; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; ODDS RATIO; PERITONEAL DIALYSIS; PREVALENCE; PROGNOSIS; RISK FACTORS; SURVIVAL ANALYSIS; UNITED STATES;

EID: 4544383695     PISSN: 10472797     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.annepidem.2004.01.001     Document Type: Article

References (20)

1. Harlan W.R., Oberman A., Grimm R., Rosati R.A. Chronic congestive heart failure in coronary artery disease: Clinical criteria. Ann Intern Med. 86:1977;133-138
2. Butman S.M., Gordon A.E., Standen J.R., Kern K.B., Hahn E. Bedside cardiovascular examination in patients with severe chronic heart failure: Importance of rest or inducible jugular venous distention. J Am Coll Cardiol. 22:1993;968-974
3. Sigurdsson E., Thorgeirsson G., Sigvaldason H., Sigfusson N. Prognostic role of cardiovascular risk factors for men with cardiomegaly (The Reykjavik Study). Am J Cardiol. 78:1996;1355-1361
4. Kannel W.B., Abbott R.D. Incidence and prognosis of unrecognized myocardial infarction: An update from the Framingham Study. N Engl J Med. 311:1984;1144-1147
5. McKee P.A., Castelli W.P., McNamara P.M., Kannel W.B. The natural history of congestive heart failure: The Framingham study. N Engl J Med. 285:1971;1441-1446
6. US Renal Data System. Comorbid conditions and correlations with mortality risk among 3399 incident hemodialysis patients. Am J Kidney Dis. 20:1992;32-38
7. Foley R.N., Parfrey P.S., Harnett J.D., Kent G.M., Murray D.C., Barre P.E. The prognostic importance of left ventricular geometry in uremic cardiomyopathy. J Am Soc Nephrol. 5:1995;2024-2031
8. Stack A.G., Saran R. Clinical correlates and mortality impact of left ventricular hypertrophy among new dialysis patients in the United States. Am J Kidney Dis. 40:2002;1202-1210
9. London G.M. Left ventricular alterations and end-stage renal disease. Nephrol Dial Transplant. 17:(suppl. 1):2002;29-36
10. Levin A., Thompson C., Ethier J., Carlisle E., Tobe S., Mendelssohn D., et al. Left ventricular mass index increase in early renal disease: Impact of decline in hemoglobin. Am J Kidney Dis. 34:1999;125-134
11. Schmieder R.E., Martus P., Klingbeil A. Reversal of left ventricular hypertrophy in essential hypertension. A meta-analysis of randomized double-blind studies. JAMA. 275:1996;1507-1513
12. Chan C.T., Floras J.S., Miller J.A., Richardson R.M., Pierratos A. Regression of left ventricular hypertrophy after conversion to nocturnal hemodialysis. Kidney Int. 61:2002;2235-2239
13. US Renal Data System. USRDS 1997 Annual Data Report, Chapter IV. 1997;National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD
14. Levey A.S., Bosch J.P., Breyer Lewis J., Greene T., Rogers N., Roth D. MDRD Study Group: A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation. Ann Intern Med. 130:1999;461-470
15. K/DOQI Clinical Practice Guidelines on Chronic Kidney Disease. Work group and evidence review team membership. Am J Kidney Dis. 39:(suppl. 1):2002;11-12
16. Eliot R., Beaubien E.R., Pylypchuk G.B., Akhtar J., Biem H.J. Value of corrected QT interval dispersion in identifying patients initiating dialysis at increased risk of total and cardiovascular mortality. Am J Kidney Dis. 39:2002;834-842
17. Bergstrom J., Lindholm B. Malnutrition, cardiac disease, and mortality: An integrated point of view. Am J Kidney Dis. 32:1998;834-841
18. Stenvinkel P., Heimbürger O., Lindholm B., Kaysen G.A., Bergström J. Are there two types of malnutrition in chronic renal failure? Evidence for relationships between malnutrition, inflammation, and atherosclerosis (MIA syndrome). Nephrol Dial Transplant. 15:2000;953-960
19. Lauer M.S., Anderson K.M., Kannel W.B., Levy D. The impact of obesity on left ventricular mass and geometry. The Framingham Heart Study. JAMA. 266:1991;231-236
20. Stack A.G. Impact of timing of nephrology referral and pre-ESRD care on mortality risk among new ESRD patients in the United State. Am J Kidney Dis. 41:2003;310-318